CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $4.01B, above the global median of $1.2B
- FinancialsAltman Z-Score 13.44: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.04%
Annual Rate
INR 0.50Paid annual
Payout Ratio
2.4%Sustainable
Last Ex-Dividend
Aug 14, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
385.19BINR4.01B · vs all stocks (USD)
Trailing P/E
72.45xvs Medical Care Facilities peers
Revenue (TTM)
46.83BINR488.06M · vs all stocks (USD)
Profit Margin
11.88%vs Medical Care Facilities peers
Beta
0.1430xvs all stocks
52-Week Change
6.92%vs all stocks
Market Capitalization
385.19BINR4.01B · vs all stocks (USD)
Enterprise Value
402.45BINR4.19B · vs all stocks (USD)
Trailing P/E
72.45xvs Medical Care Facilities peers
Forward P/E
44.49xvs Medical Care Facilities peers
Price to Sales (TTM)
8.58xvs Medical Care Facilities peers
Price to Book (MRQ)
10.14xvs Medical Care Facilities peers
Enterprise to Revenue
8.59xvs Medical Care Facilities peers
Enterprise to EBITDA
41.57xvs Medical Care Facilities peers
Gross Margin
77.43%vs Medical Care Facilities peers
Profit Margin
11.88%vs Medical Care Facilities peers
Operating Margin
16.70%vs Medical Care Facilities peers
Return on Assets (TTM)
9.42%vs Medical Care Facilities peers
Return on Equity (TTM)
13.97%vs Medical Care Facilities peers
Revenue (TTM)
46.83BINR488.06M · vs all stocks (USD)
Revenue per Share (TTM)
178.98INRUpdated Sep 29, 2026Quarterly Revenue Growth
26.50%vs Medical Care Facilities peers
Gross Profit (TTM)
24.72BINR257.65M · vs all stocks (USD)
EBITDA (TTM)
10.79BINR112.46M · vs all stocks (USD)
Net Income (TTM)
5.56BINR57.96M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-0.20%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
7.14BINR74.45M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.56BINR57.99M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.5000INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.04%vs all stocks
Payout Ratio
2.42%vs Medical Care Facilities peers
Minority Interest (Equity)
227.05MINRFY2026 · Mar 31, 2026Revenue
44.10BINRFY2026 · Mar 31, 2026Cost of Goods Sold
9.97BINRFY2026 · Mar 31, 2026Gross Profit
34.13BINRFY2026 · Mar 31, 2026Operating Income
6.97BINR72.59M · vs all stocks (USD)
Pre-tax Income
7.15BINRFY2026 · Mar 31, 2026Income Tax Expense
1.61BINRFY2026 · Mar 31, 2026Net Income
5.54BINRFY2026 · Mar 31, 2026EBIT
7.94BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
10.18BINRFY2026 · Mar 31, 2026Selling, General & Administrative
6.58BINRFY2026 · Mar 31, 2026Other Operating Expenses
7.40BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
791.14MINRFY2026 · Mar 31, 2026Minority Interests (P&L)
23.92MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
5.46BINRFY2026 · Mar 31, 2026Free Cash Flow
-2.92BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
1.27BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
7.15BINRFY2026 · Mar 31, 2026Stock-based Compensation
382.98MINRFY2026 · Mar 31, 2026Other Non-cash Items
-695.65MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.30BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-78.64MINRFY2026 · Mar 31, 2026Capital Expenditures
-8.37BINRFY2026 · Mar 31, 2026Net Intangibles (CF)
-1.40BINRFY2026 · Mar 31, 2026Purchase of Investments
-1.89BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-10.26BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
3.69BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-121.15MINRFY2026 · Mar 31, 2026Common Stock Repurchase
-98.24MINRFY2026 · Mar 31, 2026Common Dividends Paid
-134.40MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
3.57BINRFY2026 · Mar 31, 2026Shares Outstanding
268.72MSharesUpdated Sep 29, 2026Float Shares
88.41MSharesUpdated Sep 29, 2026% Held by Insiders
66.39%vs all stocks
% Held by Institutions
24.51%vs all stocks
Total Cash (MRQ)
11.30BINR117.78M · vs all stocks (USD)
Total Cash per Share (MRQ)
42.08INRUpdated Sep 29, 2026Total Debt (MRQ)
11.90BINR124.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2987xvs Medical Care Facilities peers
Current Ratio (MRQ)
2.67xvs Medical Care Facilities peers
Book Value per Share (MRQ)
147.47INRUpdated Sep 29, 2026Total Assets
59.05BINR615.36M · vs all stocks (USD)
Total Current Assets
16.75BINRFY2026 · Mar 31, 2026Total Liabilities
19.21BINRFY2026 · Mar 31, 2026Total Non-current Assets
42.30BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
12.94BINRFY2026 · Mar 31, 2026Total Current Liabilities
6.27BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
1.27BINRFY2026 · Mar 31, 2026Other Short-term Investments
10.35BINRFY2026 · Mar 31, 2026Accounts Receivable
4.11BINRFY2026 · Mar 31, 2026Inventory
789.83MINRFY2026 · Mar 31, 2026Accounts Payable
2.42BINRFY2026 · Mar 31, 2026Short-term Debt
629.89MINRFY2026 · Mar 31, 2026Other Current Liabilities
299.87MINRFY2026 · Mar 31, 2026Long-term Debt
11.27BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
522.81MINRFY2026 · Mar 31, 2026Common Stock (Book)
537.38MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
39.84BINR415.20M · vs all stocks (USD)
52-Week Low
956.00INRUpdated Sep 29, 202652-Week High
1.54KINRUpdated Sep 29, 202652-Week Change
6.92%vs all stocks
Beta
0.1430xvs all stocks
50-Day MA
1.43KINRUpdated Sep 29, 2026200-Day MA
1.23KINRUpdated Sep 29, 2026Avg 10-Day Volume
209.79KSharesUpdated Sep 29, 2026Avg 30-Day Volume
272.49KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
20.64INRUpdated Sep 29, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.44: safe zoneNotable
Altman Z-Score: 13.44
High earnings qualityNotable
Earnings Quality Score: 0.63
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $4.01B, above the global median of $1.2BNotable
Market cap (USD): 4,014,022,048.842Global Median: 1,201,862,193
Levered free cash flow is $57.99M, above the global median of $18.92MNotable
Levered free cash flow (USD): 57,988,696.6Global Median: 18,920,810.7
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Pacific Quartz Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Innodisk Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Johnson Matthey Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hangzhou Cable Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aoshikang Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Shougang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Offshore Oil Engineering Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
ASM Pacific Technology Limited
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Sai Microelectronics Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
EO Technics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Sichuan Mingxing Electric Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Soho Hotel Corporation
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth